Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy
Authors:
Open Access
- 1 August 2016
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 16 (8) , 2496-2497
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Immune Checkpoint Blockade in Cancer TherapyJournal of Clinical Oncology, 2015
- Role of the PD-1 Pathway in the Immune ResponseAmerican Journal of Transplantation, 2012
- PDL1 Is Required for Peripheral Transplantation Tolerance and Protection from Chronic Allograft RejectionThe Journal of Immunology, 2007